https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Microneedles: a smart approach and increasing potential for transdermal drug delivery system https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44995 Wed 26 Oct 2022 09:22:09 AEDT ]]> Gene therapy and type 1 diabetes mellitus https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33590 Wed 15 Dec 2021 16:08:03 AEDT ]]> Emerging landscape in psoriasis management: from topical application to targeting biomolecules https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44524 Wed 09 Nov 2022 10:21:36 AEDT ]]> The potential of siRNA based drug delivery in respiratory disorders: recent advances and progress https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44965 Tue 25 Oct 2022 13:46:05 AEDT ]]> Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47625 Tue 24 Jan 2023 14:02:31 AEDT ]]> MAPK pathway: a potential target for the treatment of non-small-cell lung carcinoma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48577 Tue 21 Mar 2023 17:30:00 AEDT ]]> QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53373 Thu 23 Nov 2023 11:03:52 AEDT ]]> Microbiome as therapeutics in vesicular delivery https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33587 Thu 22 Nov 2018 13:41:28 AEDT ]]> MicroRNAs as biological regulators in skin disorders https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33586 Thu 03 Feb 2022 12:21:26 AEDT ]]> Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: emerging need for novel drug delivery approaches https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33588 Mycobacterium tuberculosis, Mtb) treatment involves multiple drug regimens for a prolonged period. However, the therapeutic benefit is often limited by poor patient compliance, subsequently leading to treatment failure and development of antibiotic resistance. Notably, oxidative stress is a crucial underlying factor that adversely influences the various treatment regimens in tuberculosis. Little information is available with advanced drug delivery systems that could be effectively utilized, in particular, for targeting the oxidative stress in tuberculosis. Thus, this presents an opportunity to review the utility of various available, controlled-release drug delivery systems (e.g., microspheres, liposomes, niosomes, solid lipid nanoparticles, dendrimers) that could be beneficial in tuberculosis treatments. This will help the biological and formulation scientists to pave a new path in formulating a treatment regimen for multi-drug resistant Mtb.]]> Thu 03 Feb 2022 12:21:12 AEDT ]]> Emerging role of nanocarriers based topical delivery of anti-fungal agents in combating growing fungal infections https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41196 Mon 08 Jan 2024 11:45:26 AEDT ]]>